Addictions Therapeutics Market to Reach $10.24B by 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Addictions Therapeutics Market From 2026 To 2030?

The addictions therapeutics market size has experienced strong growth in recent years. It is anticipated to increase from $7.46 billion in 2025 to $7.93 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been largely due to the rising prevalence of substance use disorders, enhanced awareness concerning addiction treatment, an increasing number of specialized treatment centers, the implementation of buprenorphine and naltrexone therapies, and the widening of hospital and clinical networks.

The addictions therapeutics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $10.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. Factors driving this growth during the forecast timeframe include the creation of new addiction therapeutics, an uptick in government and private sector investment for suds programs, the expansion of telehealth and online treatment solutions, increased blending of mental health and addiction treatments, and a broader reach of public-private collaborations in addiction management. Key trends anticipated for this period encompass a heightened demand for medication-assisted treatment (mat), the proliferation of both inpatient and outpatient facilities for addiction recovery, greater uptake of telehealth and remote advisory services, an intensified focus on therapies for nicotine and opioid dependencies, and more robust awareness campaigns targeting substance use disorders.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Addictions Therapeutics Market?

The expansion of the addiction therapeutics market is anticipated to be driven by the rising intake of alcohol. Alcohol consumption describes the act of ingesting drinks that contain ethyl alcohol. Addiction therapeutics serve as treatments for alcohol dependence, assisting individuals in moderating their alcohol intake. These treatments achieve this by counteracting the depressant impacts of alcohol and fostering equilibrium between the excitatory and inhibitory neurotransmitters, namely glutamate and gamma-aminobutyric acid, within an individual. This mechanism works to diminish cravings for alcohol, ease symptoms, and mitigate withdrawal-related manifestations such as insomnia, anxiety, and general restlessness. A relevant illustration comes from December 2024, where Kirin Holdings Co. Ltd., a Japanese company dealing in alcoholic, non-alcoholic beverages, and pharmaceutical products, reported that global beer consumption in 2023 experienced a minor uptick of approximately 200,000 kl compared to the previous year, 2022. This brought the total to around 187.9 million kl, which is equivalent to roughly 296.9 billion 633 ml bottles, signifying a marginal annual growth of 0.1%. Consequently, the growing consumption of alcohol is fueling the addiction therapeutics market.

Which Segment Classifications Are Used In The Addictions Therapeutics Market Segment Analysis?

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse, Generic Disulfiram

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix), Generic Varenicline

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

Which Trends Are Shaping The Addictions Therapeutics Market?

Major companies in the addiction therapeutics market are developing innovative products, including drugs for cocaine use disorders (CUD), to reach larger customer bases, boost sales, and increase revenue. Drugs for cocaine use disorders (CUD) are medications crafted to help individuals experiencing cocaine addiction or dependence. As an illustration, in January 2023, Tempero Bio, a US-based biopharmaceutical company, announced that TMP-301 had received U.S. Food and Drug Administration (FDA) approval. The distinguishing characteristic of TMP-301, the Company’s investigational candidate, is its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Specifically designed for a key role in treating cocaine use disorders (CUD), TMP-301 is noted for its potency, selectivity, and oral availability, all aimed at effectively curbing the overactive glutamate signaling associated with CUD.

Which Firms Are Contributing To The Addictions Therapeutics Market Ecosystem?

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Get The Full Addictions Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Region Represents The Largest Share Of The Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Addictions Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Addictions Therapeutics Market 2026, By The Business Research Company

Substance Abuse And Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Substance Abuse And Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Nicotine Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795